GeneDx Holdings Corp (WGS)
20.87
+3.80
(+22.26%)
USD |
NASDAQ |
May 01, 16:00
20.80
-0.07
(-0.34%)
Pre-Market: 08:52
GeneDx Holdings Revenue (TTM): 221.85M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 221.85M |
| December 31, 2023 | 202.57M |
| September 30, 2023 | 206.50M |
| June 30, 2023 | 236.43M |
| March 31, 2023 | 223.89M |
| December 31, 2022 | 234.69M |
| Date | Value |
|---|---|
| September 30, 2022 | 231.14M |
| June 30, 2022 | 191.09M |
| March 31, 2022 | 201.94M |
| December 31, 2021 | 212.20M |
| September 30, 2021 | 218.35M |
| June 30, 2021 | 213.78M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
191.09M
Minimum
Jun 2022
236.43M
Maximum
Jun 2023
216.20M
Average
216.07M
Median
Revenue (TTM) Benchmarks
| American Well Corp | 259.05M |
| GoodRx Holdings Inc | 750.26M |
| Privia Health Group Inc | 1.658B |
| Doximity Inc | 468.33M |
| FOXO Technologies Inc | 0.453M |